Rosuvastatin Calcium CAS 147098-20-2 Assay 98.5% ~ 102.0% API Factory High Purity
Ukubonelela ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Rosuvastatin Calcium
CAS: 147098-20-2
Imveliso yoRhwebo
Igama leMchiza | Rosuvastatin Calcium |
Izithethantonye | ZD 4522 Calcium;(E) -6--[4-(4-Fluorophenyl)-6-Isopropyl-2-(Methyl-Methylsulfonyl-amino)pyrimidin-5-yl]-2,4-Dihydroxy-hex-5-Enoate;(6E)-7-{4-(4-Fluorophenyl)-6-(1-Methylethyl)-2-[Methyl(methylsulfonyl) amino]pyrimidin-5-yl}-3,5-Dihydroxyhept-6-Enoic Acid |
Inombolo yeCAS | 147098-20-2 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C44H54CaF2N6O12S2 |
Ubunzima beMolekyuli | 1001.14 |
Indawo yokunyibilika | 122℃ |
Imeko yokuthumela ngenqanawa | Ithunyelwe Ngaphantsi Kweqondo Lobushushu Le-Ambient |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kwi-Off-White Powder |
Ukujikeleziswa okuthe ngqo | +17.0 ° ~ +21.0 ° |
Ukuchongwa | A. Uyayifezekisa iMfuneko B. UV: λmax=243nm C. IR: Ifana neNxibelelaniso yeZinto D. I-X-Ray: Ifana neNgcaciso yeSithombo |
I-Chloride | ≤0.10% |
Isulphate | ≤0.10% |
I-Enantiomer | ≤0.15% |
Umxholo weCalcium | 3.5%~4.5% |
Izinto ezinxulumeneyo | |
Diastereomer | ≤0.15% |
5-Oxo-Rosucastatin | ≤0.15% |
Ukuthotywa kwefoto 1 | ≤0.15% |
Ukuthotywa kweFoto 2 | ≤0.15% |
Rosuvastatin Lactone | ≤0.15% |
I-Rosuvastatin Methyl Ester | ≤0.15% |
Rosuvastatin Isoamyl Ester | ≤0.15% |
Nakuphi na Ukungcola Okungaziwa | ≤0.10% |
Ukungcola ngokupheleleyo | ≤0.75% |
Ukufuma (KF) | ≤3.0% |
Intsimbi enzima | ≤20ppm |
Isoamyl Bromide | ≤37.5ppm |
Izinyibilikisi ezishiyekileyo | |
Ethyl Ether | ≤300ppm |
Acetonitrile | ≤410ppm |
Isoamyl Utywala | ≤5000ppm |
I-DMF | ≤880ppm |
Isivavanyi | 98.5% ~ 102.0% (ibalwe kwisiseko se-anhydrous) |
Umgangatho woVavanyo | uMgangatho woShishino;BP / USP / EP Standard |
Ukusetyenziswa | API |
Iphakheji: Ibhotile, umgqomo, igubu lekhadibhodi, 25kg / umphanda, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma
I-Rosuvastatin Calcium (i-CAS: 147098-20-2) ichiza elichasayo le-hyperlipidemia elikwi-inhibitor ye-HMG-CoA reductase ephuhliswe ngempumelelo yinkampani yaseBrithani AstraZeneca.Ilungele unyango lwe-lipid abnormalities, kubandakanywa i-hypercholesterolemia, i-lipid qualitative abnormalities kunye ne-hypertriglyceridemia elula.I-Rosuvastatin Calcium (i-CAS: i-147098-20-2) idweliswe njengezona zidakamizwa ezinamandla kakhulu kunye nezona zibanzi eziye zangena kwiimarike zokunciphisa i-lipid kunye nohlengahlengiso.Xa kuthelekiswa ne-atorvastatin ebonwa ngoku njengeyona nto isebenzayo emhlabeni, inempembelelo engcono yokunciphisa i-cholesterol ye-LDL kunye nokunyusa izinga le-high-density lipoprotein.Ngaphezu koko, inokunyamezela okungcono, imiphumo engaphantsi kwecala kunye neempawu ezizodwa ze-pharmacokinetic kunye nesiqingatha sobomi malunga ne-20h.